Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Prevention of Post-mastectomy Neuropathic Pain
NCT03686774Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Feb 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in neuropathic pain, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
memantine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03686774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686774.